The Washington Post @washingtonpost
Two members of an FDA advisory committee quit after approval of controversial Alzheimer’s drug https://t.co/5uhYUftm9m — PolitiTweet.org
Created
Wed Jun 09 23:31:02 +0000 2021
Likes
0
Retweets
0
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Washington Post @washingtonpost
Two members of an FDA advisory committee quit after approval of controversial Alzheimer’s drug https://t.co/5uhYUftm9m — PolitiTweet.org